Dose-Dependent association of cumulative tobacco consumption with the presence of carotid atherosclerosis in individuals with type 1 diabetes

Diabetes Res Clin PractPublished Cross-sectional study

Authors' conclusion

In T1D patients, CTC is dose-dependently associated with atherosclerosis. Further prospective studies are needed to determine if CTC could identify T1D individuals more prone to accelerated atherosclerosis.

Study context

Population
T1D patients without cardiovascular disease (CVD), with ≥1 of: ≥40 years old, diabetic kidney disease, and/or T1D duration ≥10 years + cardiovascular risk factors; 46.1 % women, age 48.7 ± 10.5 years, 26.2 % active smokers
Participants
584 patients
Exposure
Cumulative tobacco consumption and carotid atherosclerosis
Outcome
Association of CTC with carotid atherosclerosis (number of plaques: none, 1-2, ≥3) by carotid US

Main finding

As reported in the abstract

Number of carotid plaques (none, 1-2, ≥3)
Overall plaque prevalence
40.9 %
Cumulative tobacco consumption (CTC) dose-dependently associated with number of plaques overall and in both active and former smokers (adjusted for age, sex, lipids, blood pressure, kidney function, statin use, microvascular complications and HbA1c)
p < 0.001
Association after adjusting for Steno T1 Risk Engine (ST1RE), OR
1.11 [1.02-1.19]

Observational data: associations, not effects.

Further findings

Plaque identification with CTC added to ST1RE

No improvement overall
P = 0.180
Improved in active smokers, AUC
0.738 vs. 0.768; p < 0.01

Original publication

Dose-Dependent association of cumulative tobacco consumption with the presence of carotid atherosclerosis in individuals with type 1 diabetes. Diabetes Res Clin Pract. Published 4 July 2024. doi:10.1016/j.diabres.2024.111771

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.